- Advertising
- Asia
- Bangladesh
- Biological Inventions
- BRAND VALUATION
- China
- Comparative Advertisement
- Copyright
- Copyright Infringement
- Copyright Litigation
- Counterfeiting
- Covid
- Data Protection
- Design
- Digital Marketing Rights
- DRM
- Electronics
- Geographical Indication
- India
- Indian Patents Act
- Indonesia
- Intellectual Property
- Interim Injunction
- IP Commercialization
- IP Licensing
- IP Litigation
- IP Practice in India
- IPAB
- IPAB Decisions
- Japan
- Legal Issues
- Licensing
- Malaysia
- Myanmar
- NCLT
- NEPAL
- Net Neutrality
- News & Updates
- Office
- Patent Commercialisation
- Patent Cooperation Treaty
- patent infringement
- Patent Licensing
- Patent Litigation
- Patent Opposition
- Patent Prosecution
- Patent Rule Amendment
- Patent Term Extension
- Patents
- pharma
- Philippines
- Punitive Damages
- Section 3(D)
- section 64
- Singapore
- South-east Asia
- Technology
- Technology Transfer
- Thailand
- Trademark
- Trademark Litigation
- UAE
- Uncategorized
- USPTO
- Vietnam
- WIPO
Compulsory Licensing in India Amidst the COVID 19 Pandemic: Will India Consider it?
The COVID-19 pandemic has truly exposed the frailty of our infrastructural systems. Innovation has taken a front seat and the world is keenly awaiting the public distribution of COVID-19 vaccines which would help restore normalcy. Among the numerous factors that were taken into consideration by global experts with respect to the COVID 19 vaccines, accessibility … Continue reading Compulsory Licensing in India Amidst the COVID 19 Pandemic: Will India Consider it?
Read more »Pharmaceutical Patents a Threat to India’s Drug Industry?
The Indian Pharmaceutical industry is one of the largest, ranked fourth in the world in respect to the production volume. Over the last three decades, the industry’s growth has resulted from no existence to a world leader in terms of production of high quality generic drugs. Prior to 2005, no patent was granted on medicines … Continue reading Pharmaceutical Patents a Threat to India’s Drug Industry?
Read more »Three Days International Symposium on Strategies for Managing Pharmaceutical, Biotechnology and Chemical Patent Portfolios (United States, European and Chinese Scenario)
We are happy to inform you all that IIPRD and Khurana & Khurana, in association with Sughrue Mion, PLLC, USA, TEE & HOWE IP ATTORNEYS, CHINA and MAIWALD, GERMANY are holding an International Patent Symposium covering all major and relevant Pharmaceutical, Biotechnology, and Chemical Patent Portfolios in the month of October 2015 in India. The … Continue reading Three Days International Symposium on Strategies for Managing Pharmaceutical, Biotechnology and Chemical Patent Portfolios (United States, European and Chinese Scenario)
Read more »Revised Draft Guidelines for Examination of Pharma Patent Applications
August 22, 2014 - 8:23 am
Categories:
India
IP Practice in India
News & Updates
Patents
pharma
0 Comments We have earlier reported the release of Draft Guidelines for Examination of Pharma Patent Applications. The Patent Office has now released revised draft guidelines and in continuation of our earlier article here, we explain herein what those revisions are and the impact of the guidelines in general. The revised guidelines of 12th August 2014 are … Continue reading Revised Draft Guidelines for Examination of Pharma Patent Applications
Read more »Examination Guidelines for Pharmaceuticals Patents
There has been limited judicial consideration of how patent law applies to pharmaceutical inventions in India. Little specific guidance is available to patent examiners in assessing whether a particular pharmaceutical invention satisfies the requirements for patentability. The absence of judicial guidance in this area is problematic. Indian Patent Office has published the Draft Guidelines on … Continue reading Examination Guidelines for Pharmaceuticals Patents
Read more »